Upcoming Events
Log In
Pricing
Free Trial

Wk 2, Case 5 - Review

HIDE
PrevNext

0:00

Once again, we go right to the SAGE.

0:03

Easy-peasy.

0:04

Everybody knows how to look at a lateral

0:06

conventional radiograph, so why not?

0:09

We've got two sagittals.

0:11

I think we'll take one other projection.

0:15

Let's take an axial T2, since it's

0:17

available, and we have no other sagittals.

0:20

So we have a proton, actually a T2, with a T of 68.

0:26

I'm not thrilled with that TE.

0:27

12 00:00:28,400 --> 00:00:30,410 I'd either like it to be 40 or a hundred.

0:30

This is kind of a no man's land, but okay.

0:33

It's a T2 with fat suppression.

0:36

It's a T1 without fat suppression.

0:39

It's a T2 without fat suppression.

0:41

That's scroll.

0:45

We talked about erosions.

0:47

That could be central or

0:49

marginal or para-articular.

0:52

So-called pressure erosions.

0:56

These pressure erosions can be quite large.

0:59

They're due to increased intra-articular pressure.

1:03

They produce a scalloped, yet well-

1:06

defined sclerotic border, and they are

1:09

a cardinal feature of this diagnosis.

1:12

Here's another set of pressure

1:14

erosions in the subtalar space.

1:19

A couple of other features of this, this

1:22

abnormality, um, one feature besides the

1:26

distention and the pressure erosions.

1:29

Is the signal.

1:31

The signal is very low on

1:33

everything except the T1.

1:37

It's very low on the T2.

1:38

It's very low on the PD spur.

1:42

And they failed to give you a gradient

1:44

echo, which would have been lovely.

1:47

This is just another fat suppression sequence.

1:50

And the reason a gradient echo would have

1:52

been lovely because when you go from a

1:54

spin echo to a gradient echo, and you have

2:00

something that has blood or iron in it, which

2:03

this does, That blood or iron is going to

2:05

get much darker, and it's going to distort

2:08

the tissues, and that's known as blooming.

2:12

But this case is so grotesque and

2:14

obvious that you don't need that.

2:18

There's not too many things inside

2:21

a joint that are going to be black.

2:23

Let's talk about a few of them.

2:25

Air.

2:26

This isn't black enough for air.

2:28

Plus, it's got stuff in it.

2:29

It's gray on the T1.

2:31

Air is black.

2:32

Flow.

2:33

Flow is either going to be black

2:35

or white depending upon the speed.

2:37

These things aren't tubular.

2:40

Metal.

2:41

That's a possibility, but that would

2:43

be a lot of metal in the joint.

2:45

How does metal get into a joint?

2:47

From a joint replacement.

2:49

That's called metalosis or aseptic

2:50

lymphovascular-associated lesions.

2:54

Some of which are metal-containing.

2:57

So metal is out clinically.

3:01

Blood.

3:02

You could have a hemorrhage, but

3:04

a hemorrhage is going to have some

3:06

methemoglobin associated with it.

3:09

I don't see any methemoglobin, but I do see some

3:12

high signal, which is corticated right there.

3:17

And that is a focal area of osteochondromatosis,

3:21

part of this metaplastic process right here.

3:25

What's another cause of intra-articular blood?

3:29

Hemophilia.

3:31

Probably one you hadn't thought of.

3:33

They get big pseudotumors.

3:35

They're notorious for producing pressure erosions.

3:38

They usually bleed in one locus.

3:40

We don't see it as much today because of the

3:42

skill and training of our rheumatologists and

3:45

internists in dealing with factor VIII deficiency.

3:49

So it's uncommon.

3:51

It also tends to be in one

3:52

quadrant, not in multiple quadrants.

3:56

Usually, the patients are so uncomfortable that

3:59

it gets addressed in the single quadrant that

4:01

it's in. They get factor eight, and if it's a

4:04

big enough pseudotumor, it will get excised.

4:07

Here we have a patient where the process is

4:09

slowly, slowly, slowly progressed in more than

4:13

one compartment. It's posterior, it's anterior,

4:16

it's subtalar, and if we look coronally, it is

4:19

lateral, sorry, it is lateral, and to a lesser

4:22

extent, it is It is medial, not so much medial.

4:27

So the diagnosis here is pigmented villonodular

4:32

synovitis, and it's the diffuse type.

4:35

So what types of pigmented

4:36

villonodular synovitis do you have?

4:39

You got focal, which is also known as

4:43

localized giant cell tumor of tendon sheath.

4:45

Same thing.

4:46

It's a synonym.

4:48

Then you have diffuse, where it's everywhere.

4:52

That's this case.

4:54

Then you have multifocal, where you

4:57

have nodules, but they're discrete

4:59

nodules in more than one quadrant.

5:02

And then you have non-pigmented villonodular

5:07

synovitis or villonodular synovitis.

5:11

And that is a tricky one.

5:14

It looks like this on the T1, but doesn't have

5:16

this degree of dark signal intensity on the water

5:20

weighted sequences because it's maybe not devoid

5:23

of hemosiderin, but has very scant hemosiderin,

5:26

which can only be seen on the gradient echo image.

5:30

Now, pigmented villonodular synovitis falls

5:33

into the family of synovial metaplasias.

5:36

So there can be some overlap.

5:39

There is a heredofamilial predilection for this

5:43

condition, but it is not discreetly inherited.

5:47

In other words, family members who

5:49

have had it, the risk of another

5:50

family member having it is increased.

5:53

But nobody knows what factors cause it, although

5:57

friction and a certain subgroup of the population

6:00

is believed to be the underlying etiology.

6:04

So let's talk about the synovial metaplasias.

6:07

We've got pigmented villonodular synovitis,

6:13

and the subtypes of villonodular synovitis

6:15

that we gave you earlier, all four of them.

6:18

So there'll be four of those.

6:20

Then we've got synovial chondromatosis,

6:26

and those are usually round objects

6:28

that look more like cartilage.

6:30

They are not pigmented and do not

6:32

give you this dark signal intensity,

6:34

and they don't give you blooming.

6:37

Then you've got ossified synovial

6:40

chondromatosis, where you have the same

6:43

thing as SC, but they have marrow in them.

6:46

I showed you one.

6:47

Ossicle that was mixed in with

6:50

the PVNS, that little white object

6:53

with the ring of cortex around it.

6:57

Then you've got lipoma arborescens, where

7:00

you have intraarticular fatty proliferation.

7:05

And then one more, you've got

7:06

synovial hemangiomatous proliferation.

7:10

So that's actually one, two, three, four, five,

7:15

and then four subtypes of, uh, villonodular

7:19

synovitis or pigmented villonodular synovitis.

7:22

Okay.

7:23

Um, one, one other parting note on,

7:25

on synovial metaplegia is anywhere.

7:27

There are two, two treatments.

7:30

Well, actually, there are three treatments

7:32

for synovial metaplastic disease.

7:34

One, the most advanced grotesque

7:38

treatment is to resect the joint.

7:41

In other words, do a hip replacement.

7:43

I've, I've, I've done that in 20

7:45

year-olds who had very severe PVNS

7:47

and they have done, done terrific.

7:50

Um, another treatment, which

7:53

is less invasive, invasive,

7:55

is to go in and do a synovectomy.

7:58

To do that, you need to map out

8:00

where the PVNS is for the surgeon.

8:02

It's lateral, it's subtalar, it's posterior

8:05

and to a lesser extent it's medial.

8:07

So you, you are the mapper, uh,

8:10

for that surgical procedure.

8:12

And then you can also use a beta emitter

8:14

and put that in the joint ligament.

8:16

And, uh, you know, that can be done

8:18

by an interventional radiologist

8:20

or an orthopedic surgeon.

8:21

Musculoskeletal radiologists.

8:23

It's just putting a needle in the joint and making

8:25

sure your beta emitter gets into the right place.

8:28

That's the least common therapy

8:30

and the least invasive of all.

8:35

Would gout be a reasonable differential

8:37

diagnosis with juxta-articular erosions?

8:40

It would, but not in this case.

8:42

The signal intensity of gout is not this black.

8:46

It's not this dark.

8:48

Um, it also happens to be a woman.

8:51

So, you know, you don't see gout that

8:53

often in women, but this very, very dark

8:55

signal is not characteristic of gout.

8:58

Gout tends to be intermediate, more

9:00

close to the signal intensity of

9:02

muscle, and that's also true for TOFI.

9:06

Too dark for gout.

9:09

Wrong gender.

Report

Patient History
56-year-old woman with previous injury to the peroneal tendons now complaining of chronic foot/ankle pain.

Findings
SKELETAL/BONES:
Pressure erosions throughout the ankle, most prominent at the dorsal aspect of the talus and inferior talus surrounding the sinus tarsi. Further smaller pressure erosion posterior distal fibular tip.

No aggressive osseous abnormality. No reactive osteoedema, micro- or macro-trabecular fracture.

ARTICULATIONS:
Tibiotalar joint/talar dome: Extensive metaplastic tumefactive synovial thickening throughout the entire ankle, most pronounced laterally, anterolaterally and anteriorly, with innumerable scattered low signal foci of siderosis, consistent with PVNS.

Ankle mortise/syndesmosis: The ankle mortise is in anatomic alignment. No syndesmotic widening.

Chopart joint: Tumefactive synovial thickening with foci of susceptibility/siderosis through the sinus tarsi and adjacent to the posterior facet of the subtalar joint.

Midfoot/hindfoot: No fracture or injury of the anterior calcaneal process. No prominent midfoot or hindfoot arthrosis.

LIGAMENTS:
High ankle: Completely insinuated and obscured by the metaplastic tumefactive synovial mass.

Low ankle: Completely insinuated and obscured by the metaplastic effective synovial mass.

Subtalar/Chopart: Intact.

TENDONS:
The metaplastic tumefactive synovial mass completely encases the peroneal tenosynovial complex, containing the tendons within it, extending from 5 cm above the fibular tip to approximately 2 cm proximal to the peroneus brevis tendon insertion at the base of the 5th metatarsal. Total craniocaudal extent of the mass is approximately 10 cm length.

Otherwise intact extensor, flexor and Achilles tendons.

GENERAL:
Sinus tarsi: Tumefactive synovial thickening throughout the sinus tarsi with adjacent talar pressure erosion.

Muscles: Unremarkable.

Soft tissue: Bimalleolar soft tissue edema.

Plantar fascia: Diffuse mildly to moderately thickened central cord of the plantar fascia, consistent with chronic plantar fasciitis. No evidence for active plantar fasciitis.

Neurovascular complex/tarsal tunnel: Unremarkable. No evidence of entrapment neuropathy.

Intra-articular/loose bodies: None.

Discussions
1. Massive PVNS involving the ankle joint, subtalar joint and peroneal longus and brevis tendons/tendon sheaths. Mass measures approximately 10 cm in craniocaudal dimension.
2. Complete encasement/involvement of the peroneal tenosynovial complex.
3. Prominent pressure erosions surrounding the ankle joint and sinus tarsi.

Case Discussion

Faculty

Stephen J Pomeranz, MD

Chief Medical Officer, ProScan Imaging. Founder, MRI Online

ProScan Imaging

Jenny T Bencardino, MD

Vice-Chair, Academic Affairs Department of Radiology

Montefiore Radiology

Edward Smitaman, MD

Clinical Associate Professor

University of California San Diego

Tags

Musculoskeletal (MSK)

MRI

Foot & Ankle

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy